Physician profile
Mchaley Hoffman
NPI 1700413515
$2,054.17
in general payments reported to CMS, 2019-2025
20 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.16 · 2022: $467 · 2023: $661 · 2024: $473 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $493.71 | 2022-2025 | |
| Novo Nordisk INC | $305.13 | 2021-2025 | Ozempic, Rybelsus, Tresiba |
| Astrazeneca Pharmaceuticals LP | $193.14 | 2023-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $185.06 | 2022-2025 | Mounjaro, Trulicity, Zepbound |
| Amgen INC. | $162.19 | 2023-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $139.11 | 2022-2024 | Trelegy Ellipta, Bexsero, Shingrix |
| Merck Sharp & Dohme LLC | $131.97 | 2021-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Pfizer INC. | $117.36 | 2022-2025 | |
| Viiv Healthcare Company | $68.69 | 2022-2024 | Cabenuva |
| Phathom Pharmaceuticals, INC. | $49.14 | 2024-2025 | Voquezna |
| Hologic Sales and Service, LLC | $35.01 | 2025 | Aptima |
| Sanofi-Aventis U.S. LLC | $32.36 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.01 | 2024 | |
| Biogen, INC. | $20.05 | 2025 | Zurzuvae |
| Esperion Therapeutics, INC. | $19.02 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $15.89 | 2025 | Fluad, Flucelvax |
| Organon LLC | $15.65 | 2021 | |
| Gilead Sciences, INC. | $15.59 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.33 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mchaley Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.